1314009

氢氯噻嗪

United States Pharmacopeia (USP) Reference Standard

• 同義詞: 6-氯-3,4-二氢-2H-1,2,4-苯并噻二嗪-7-磺酰胺1,1-二氧化物, 6-氯-7-磺酰胺-3,4-二氢-1,2,4-苯并噻二嗪-1,1-二氧化物
• 經驗公式（希爾表示法）: C₇H₈ClN₃O₄S₂
• CAS號碼: 58-93-5
• 分子量：: 297.74
• MDL號碼: MFCD00051765
• 分類程式碼代碼: 41116107
• PubChem物質ID: 329750021
• NACRES: NA.24

屬性

• 等級: pharmaceutical primary standard
• API 家族: hydrochlorothiazide
• 製造商／商標名: USP
• 應用: pharmaceutical (small molecule)
• 形式: neat
• SMILES 字串: NS(=O)(=O)c1cc2c(NCNS2(=O)=O)cc1Cl
• InChI: 1S/C7H8ClN3O4S2/c8-4-1-5-7(2-6(4)16(9,12)13)17(14,15)11-3-10-5/h1-2,10-11H,3H2,(H2,9,12,13)
• InChI 密鑰: JZUFKLXOESDKRF-UHFFFAOYSA-N
• 基因資訊: human ... SLC12A3(6559)

描述

一般說明

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

應用

Hydrochlorothiazide USP reference standard for use in specified quality tests and assays.

Also used to prepare standard, standard stock, system suitability, Hydrochlorothiazide standard solutions for assay, performance, and impurity analysis according to given below monographs of the United States Pharmacopeia (USP):

• Hydrochlorothiazide Capsules[1]
• Amiloride Hydrochloride and Hydrochlorothiazide Tablets[2]
• Captopril and Hydrochlorothiazide Tablets[3]

生化／生理作用

碳酸酐酶抑制剂

分析報告

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

其他說明

Sales restrictions may apply.

安全資訊

• 象形圖: GHS08
• 訊號詞: Warning
• 危險聲明: H351
• 防範說明: P201 - P202 - P280 - P308 + P313 - P405 - P501
• 危險分類: Carc. 2
• 儲存類別代碼: 11 - Combustible Solids
• 水污染物質分類（WGK）: WGK 2
• 閃點（°F）: Not applicable
• 閃點（°C）: Not applicable